TY - JOUR
T1 - Distinctive facies, macrocephaly, and developmental delay are signs of a PTEN mutation in childhood
AU - Kato, Kohji
AU - Mizuno, Seiji
AU - Inaba, Mie
AU - Fukumura, Shinobu
AU - Kurahashi, Naoko
AU - Maruyama, Koichi
AU - Ieda, Daisuke
AU - Ohashi, Kei
AU - Hori, Ikumi
AU - Negishi, Yutaka
AU - Hattori, Ayako
AU - Saitoh, Shinji
N1 - Funding Information:
This study was partly supported by JSPS KAKENHI Grant Number 16 K15530 (SS), and the Program for an Integrated Database of Clinical and Genomic Information from the Japanese Agency for Medical Research and Development (AMED, JP17kk0205002) (SS).
Publisher Copyright:
© 2018 The Japanese Society of Child Neurology
PY - 2018/9
Y1 - 2018/9
N2 - Background: Germline mutations of the PTEN gene are responsible for several PTEN hamartoma tumor syndromes. They are also implicated as a cause of macrocephaly and mild to severe developmental delay, regardless of the presence or absence of hamartomas in childhood. Nevertheless, because of limited information, the clinical features present during childhood in patients with a PTEN mutation are yet to be elucidated. Methods: PTEN mutations were investigated by multiplex targeted sequencing of genomic DNA from 33 children with increased head circumference (>+2 SD) and developmental delay. The clinical features of all the patients with a PTEN mutation were abstracted by dysmorphologists. Results: We have identified six children with a PTEN mutation. Clinical dissection of these six patients, in addition to patient reports in the literature, revealed distinctive facial features that included frontal bossing, dolichocephaly, horizontal eyebrows, and a depressed nasal bridge. Macrocephaly (+3.2 to +6.0 SD) was noticeable compared to their height (−0.8 to +2.1 SD), and the difference in the SD value of head circumference and height was more than 3 SD in all patients. Conclusion: The presence of distinctive facies, extreme macrocephaly with normal to mildly high stature, and developmental delay may be useful for identifying patients with a PTEN mutation in childhood. Early identification of patients with a PTEN mutation would help uncover the natural course of tumor development in this group of individuals who have a possible predisposition to cancer, and be important for the development of an optimal surveillance strategy.
AB - Background: Germline mutations of the PTEN gene are responsible for several PTEN hamartoma tumor syndromes. They are also implicated as a cause of macrocephaly and mild to severe developmental delay, regardless of the presence or absence of hamartomas in childhood. Nevertheless, because of limited information, the clinical features present during childhood in patients with a PTEN mutation are yet to be elucidated. Methods: PTEN mutations were investigated by multiplex targeted sequencing of genomic DNA from 33 children with increased head circumference (>+2 SD) and developmental delay. The clinical features of all the patients with a PTEN mutation were abstracted by dysmorphologists. Results: We have identified six children with a PTEN mutation. Clinical dissection of these six patients, in addition to patient reports in the literature, revealed distinctive facial features that included frontal bossing, dolichocephaly, horizontal eyebrows, and a depressed nasal bridge. Macrocephaly (+3.2 to +6.0 SD) was noticeable compared to their height (−0.8 to +2.1 SD), and the difference in the SD value of head circumference and height was more than 3 SD in all patients. Conclusion: The presence of distinctive facies, extreme macrocephaly with normal to mildly high stature, and developmental delay may be useful for identifying patients with a PTEN mutation in childhood. Early identification of patients with a PTEN mutation would help uncover the natural course of tumor development in this group of individuals who have a possible predisposition to cancer, and be important for the development of an optimal surveillance strategy.
UR - http://www.scopus.com/inward/record.url?scp=85046625760&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85046625760&partnerID=8YFLogxK
U2 - 10.1016/j.braindev.2018.04.008
DO - 10.1016/j.braindev.2018.04.008
M3 - Article
C2 - 29752200
AN - SCOPUS:85046625760
SN - 0387-7604
VL - 40
SP - 678
EP - 684
JO - Brain and Development
JF - Brain and Development
IS - 8
ER -